SCHEMBL5899050

SCHEMBL5899050

Cc1cc(C)cc(C(C=O)c2ccnc(N)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 4/20 0.46
NOS2 P35228 4/20 0.46
NOS1 P29475 3/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
CBLB Q13191 1/20 0.35
GABRP O00591 2/20 0.34
GABRD O14764 2/20 0.34
GABRA1 P14867 2/20 0.34
GABRB1 P18505 2/20 0.34
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
GABRA5 P31644 2/20 0.34
GABRA3 P34903 2/20 0.34
GABRA2 P47869 2/20 0.34
GABRB2 P47870 2/20 0.34
GABRA4 P48169 2/20 0.34
GABRE P78334 2/20 0.34
GABRA6 Q16445 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499677 0.84 UHRF1 (0.42) DYRK1APSEN1PSEN2APH1BNCSTN
SCHEMBL6499767 0.78 CYP3A4 (0.35) MEN1KMT2A
SCHEMBL6499586 0.72 PSEN1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6503969 0.72 GABRA5 (0.39) GABRPGABRDGABRA1GABRB1GABRG2
Bromide SCHEMBL7021922 0.71 IDO1 (0.32) NOS3NOS2NOS1KDM4EMEN1
SCHEMBL6501548 0.70 CFTR (0.41) KDM4E
SCHEMBL318126 0.69 NOS3 (0.48) NOS3NOS2NOS1KDM4EMEN1
SCHEMBL84401 0.68 NOS3 (0.52) NOS3NOS2NOS1KDM4EMEN1
SCHEMBL3660321 0.68 PSEN1 (0.40) KMT2ADYRK1APSEN1PSEN2APH1B
SCHEMBL6510105 0.68 MAPKAPK2 (0.44) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7101899-B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-09-05 US disclosed